Drugs
In a bid to reimagine its public image, DuPont, a leading chemical company, has launched a global television advertising campaign to highlight its contributions to daily life and emphasize its life sciences focus. Entitled "To do list for the planet," the campaign is a first for the company,
Drugs
Schering Berlin Inc., a wholly-owned subsidiary of Schering AG, Germany, and Diatide Inc., a New Hampshire-based pharmaceutical company, have announced that Schering Berlin Inc. will acquire Diatide for a cash payment of $9.50 per share of common stock. This acquisition is part of Schering Berlin Inc.'s global
Drugs
The online community at Lycos.com is buzzing with upcoming chats featuring notable personalities from various fields. Matthew Margolis, a.k.a. "Uncle Matty," a national dog training expert and PBS star, will share his expertise with dog owners on September 21. Film and television star Danny Masterson
Drugs
Dendrite International, a global provider of specialized sales and marketing solutions for the pharmaceutical and consumer package goods (CPG) industries, has announced a comprehensive services agreement with Eli Lilly and Company, a leading global research-based pharmaceutical corporation. This agreement is designed to support Lilly's US sales and management
Pharmaceutical industry
A preliminary FBI inquiry into American Home Products (AHP), the fifth-largest U.S. drug maker, has triggered market concerns after reports emerged that the company may have lied to regulators or withheld information about the potentially fatal side effects of their diet drugs, Pondimin and Redux. The investigation comes as
Pharmaceutical industry
ASARCO Incorporated, one of the world's leading integrated producers of copper, has completed a transaction with Coeur d'Alene Mines where it acquires a 19.3% common stock interest in the latter in exchange for its silver mining interests. The transaction, approved by Coeur d'Alene
Drugs
Pharmaceutical companies are facing increasing scrutiny from the FDA regarding their computer systems, as inspections reveal a trend of deficiencies that may lead to regulatory issues. Industry experts warn that a lack of system requirements, inadequate validation documentation, and inadequate protocols have become common findings during FDA audits. The consequences
Drugs
Familial adenomatous polyposis (FAP) is a rare genetic disorder characterized by the development of numerous adenomatous polyps in the colon and rectum, often associated with elevated COX-2 expression. These polyps are precursors to colorectal cancer, and left untreated, nearly all patients develop the disease by age 40-50. G.D. Searle
Drugs
LeukoSite, Inc. and ILEX Oncology, Inc. have entered into a distribution and development agreement with Schering AG for the humanized monoclonal antibody CAMPATH(R), which is in late-stage development for the treatment of chronic lymphocytic leukemia (CLL). Under the agreement, Schering AG will have exclusive marketing and distribution rights for
Drugs
The introduction of the birth control pill, The Pill, in 1960 has significantly impacted family planning and reproductive health. However, despite its popularity, women often struggle with remembering to take their pill every day, as highlighted in a 1998 Gallup Survey of Contraceptive Use Among Women 18-44. Almost half of
Drugs
Corixa Corporation, a biotechnology company based in Seattle, Washington, and Zenyaku Kogyo Co., Ltd., a Japanese pharmaceutical company, have entered into a multi-year license, research and development agreement for the psoriasis immunotherapeutic product, PVAC. The agreement grants Zenyaku Kogyo exclusive rights to PVAC in Japan, while Corixa and Genesis Research
Drugs
CytoTherapeutics, Inc. announced a net loss of $1,840,000 for the second quarter ended June 30, 1999, compared to a net loss of $4,048,000 in the second quarter of 1998. The company's revenues from collaborative arrangements increased by 32% to $2,521,000, driven by
